IS5231A - Vefjaþáttur sem hefur áhrif á blóðæðarmyndun - Google Patents
Vefjaþáttur sem hefur áhrif á blóðæðarmyndunInfo
- Publication number
- IS5231A IS5231A IS5231A IS5231A IS5231A IS 5231 A IS5231 A IS 5231A IS 5231 A IS5231 A IS 5231A IS 5231 A IS5231 A IS 5231A IS 5231 A IS5231 A IS 5231A
- Authority
- IS
- Iceland
- Prior art keywords
- blood vessels
- tissue factor
- factor affecting
- affecting blood
- influencing
- Prior art date
Links
- 102000002262 Thromboplastin Human genes 0.000 title abstract 2
- 108010000499 Thromboplastin Proteins 0.000 title abstract 2
- 210000004204 blood vessel Anatomy 0.000 title abstract 2
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000029663 wound healing Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/36—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Genetics & Genomics (AREA)
- Gastroenterology & Hepatology (AREA)
- Dermatology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Instructional Devices (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
- Materials For Medical Uses (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19719652A DE19719652A1 (de) | 1997-05-09 | 1997-05-09 | Tissue-Faktor zur Förderung von Wundheilung |
| DEPCT/DE98/01278 | 1998-05-07 | ||
| PCT/DE1998/001306 WO1998051321A1 (de) | 1997-05-09 | 1998-05-08 | Tissue-faktor zur beeinflussung von gefässbildung |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IS5231A true IS5231A (is) | 1999-10-26 |
Family
ID=7829124
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IS5231A IS5231A (is) | 1997-05-09 | 1999-10-26 | Vefjaþáttur sem hefur áhrif á blóðæðarmyndun |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0980251B1 (is) |
| JP (1) | JP2001527555A (is) |
| AT (1) | ATE222501T1 (is) |
| AU (1) | AU746782B2 (is) |
| CA (1) | CA2288117A1 (is) |
| CZ (1) | CZ293005B6 (is) |
| DE (2) | DE19719652A1 (is) |
| DK (1) | DK0980251T3 (is) |
| ES (1) | ES2184299T3 (is) |
| HU (1) | HUP0003831A3 (is) |
| IS (1) | IS5231A (is) |
| NO (1) | NO995459D0 (is) |
| PL (1) | PL336662A1 (is) |
| PT (1) | PT980251E (is) |
| SI (1) | SI0980251T1 (is) |
| WO (1) | WO1998051321A1 (is) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5986065A (en) | 1997-03-10 | 1999-11-16 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
| US7749498B2 (en) | 1997-03-10 | 2010-07-06 | Genentech, Inc. | Antibodies for inhibiting blood coagulation and methods of use thereof |
| US20060235209A9 (en) | 1997-03-10 | 2006-10-19 | Jin-An Jiao | Use of anti-tissue factor antibodies for treating thromboses |
| US20030109680A1 (en) | 2001-11-21 | 2003-06-12 | Sunol Molecular Corporation | Antibodies for inhibiting blood coagulation and methods of use thereof |
| DE19719652A1 (de) * | 1997-05-09 | 1998-12-03 | Merckle Gmbh | Tissue-Faktor zur Förderung von Wundheilung |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5770209A (en) * | 1991-08-30 | 1998-06-23 | University Of South Florida | Acceleration of wound healing using connective tissue growth factor |
| AU5093593A (en) * | 1992-08-28 | 1994-03-29 | Scripps Research Institute, The | Inhibition of tumor metastasis via neutralization of tissue factor function |
| FR2696095B1 (fr) * | 1992-09-30 | 1994-11-25 | Inoteb | Colle biologique à base de protéines coagulables par la thrombine, enrichie en facteurs plaquettaires, sa préparation et son application. |
| JPH10502534A (ja) * | 1994-07-12 | 1998-03-10 | ヒューマン・ジェノム・サイエンシズ・インコーポレイテッド | 結合組織増殖因子−２ |
| US5981471A (en) * | 1997-02-06 | 1999-11-09 | Entremed, Inc. | Compositions and methods for inhibiting cellular proliferation |
| DE19719652A1 (de) * | 1997-05-09 | 1998-12-03 | Merckle Gmbh | Tissue-Faktor zur Förderung von Wundheilung |
-
1997
- 1997-05-09 DE DE19719652A patent/DE19719652A1/de not_active Ceased
-
1998
- 1998-05-08 JP JP54869198A patent/JP2001527555A/ja active Pending
- 1998-05-08 PT PT98933500T patent/PT980251E/pt unknown
- 1998-05-08 HU HU0003831A patent/HUP0003831A3/hu unknown
- 1998-05-08 PL PL98336662A patent/PL336662A1/xx unknown
- 1998-05-08 ES ES98933500T patent/ES2184299T3/es not_active Expired - Lifetime
- 1998-05-08 SI SI9830279T patent/SI0980251T1/xx unknown
- 1998-05-08 AT AT98933500T patent/ATE222501T1/de not_active IP Right Cessation
- 1998-05-08 EP EP98933500A patent/EP0980251B1/de not_active Expired - Lifetime
- 1998-05-08 DK DK98933500T patent/DK0980251T3/da active
- 1998-05-08 AU AU83315/98A patent/AU746782B2/en not_active Ceased
- 1998-05-08 CA CA002288117A patent/CA2288117A1/en not_active Abandoned
- 1998-05-08 WO PCT/DE1998/001306 patent/WO1998051321A1/de not_active Ceased
- 1998-05-08 CZ CZ19993912A patent/CZ293005B6/cs not_active IP Right Cessation
- 1998-05-08 DE DE59805246T patent/DE59805246D1/de not_active Expired - Fee Related
-
1999
- 1999-10-26 IS IS5231A patent/IS5231A/is unknown
- 1999-11-08 NO NO995459A patent/NO995459D0/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU8331598A (en) | 1998-12-08 |
| ES2184299T3 (es) | 2003-04-01 |
| SI0980251T1 (en) | 2003-02-28 |
| DE59805246D1 (de) | 2002-09-26 |
| EP0980251A1 (de) | 2000-02-23 |
| EP0980251B1 (de) | 2002-08-21 |
| AU746782B2 (en) | 2002-05-02 |
| NO995459L (no) | 1999-11-08 |
| CZ293005B6 (cs) | 2004-01-14 |
| JP2001527555A (ja) | 2001-12-25 |
| NO995459D0 (no) | 1999-11-08 |
| WO1998051321A1 (de) | 1998-11-19 |
| HUP0003831A2 (hu) | 2001-02-28 |
| DE19719652A1 (de) | 1998-12-03 |
| WO1998051321A9 (de) | 1999-04-01 |
| DK0980251T3 (da) | 2002-11-18 |
| PL336662A1 (en) | 2000-07-03 |
| CZ391299A3 (cs) | 2000-04-12 |
| PT980251E (pt) | 2003-01-31 |
| CA2288117A1 (en) | 1998-11-19 |
| ATE222501T1 (de) | 2002-09-15 |
| HUP0003831A3 (en) | 2003-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60023043T2 (de) | (S,S)-Reboxetin zur Behandlung von Inkontinenz | |
| FR2770767B1 (fr) | Implant pour vertebre | |
| DE10085007T1 (de) | Antiinfektionszusammensetzungen zur Behandlung von erkranktem Gewebe, wie Lippenherpes | |
| SE9701162D0 (sv) | New use II | |
| BR9906477A (pt) | Cicatrizante de feridas enriquecido com plaquetas aperfeiçoado | |
| EE9700225A (et) | Meetod diabetes mellituse raviks, kasutades KKF | |
| NO971341D0 (no) | Promoter for reseptor tyrosinkinase TIE | |
| ATE368455T1 (de) | Verwendung von (+)-tramadol, o-demethyltramadol, o-desmethyl-n-mono-desmethyl-tramadol zur therapie der harninkontinenz | |
| IS5231A (is) | Vefjaþáttur sem hefur áhrif á blóðæðarmyndun | |
| EA200200853A1 (ru) | Применение 2-метилтиазолидин-3,3-дикарбоновой кислоты (2-мтдк) и/или ее физиологически совместимых солей для лечения и/или предупреждения рака | |
| AU2001232053A1 (en) | System for the extracorporeal treatment of blood | |
| PT869785E (pt) | 4-hidroxicumarina-3-carboxamidas para o tratamento de diabetes mellitus nao insulinodependente | |
| ATE222103T1 (de) | Inklusionskomplexe in waessriger loesung | |
| FR2715945B1 (fr) | Tissu. | |
| ZA983753B (en) | Medicinal composition for treatment of burns, cuts and like wounds. | |
| NO984965L (no) | Komponent B som cicatrisant | |
| UA32315A (uk) | Спосіб накладання шкірного шва | |
| GB9812278D0 (en) | Use of a wound dressing in the treatment of acute wounds | |
| DE69832075D1 (de) | Verwendung von eprosartan zur behandlung von isoliertem systolischem bluthochdrucks | |
| ZA982679B (en) | Medicinal composition for treatment of burns, cuts and like wounds. | |
| UA36465A (uk) | Спосіб ушивання глибоких і нешироких ран та голка для його здійснення | |
| UA32280A (uk) | Спосіб формування тонко-товстокишкового анастомозу бік у бік | |
| SE9802075D0 (sv) | New use | |
| EP1483396A4 (en) | NEW GENE WIT 3.0, FOR HEALING OF LESIONS IN SOFT TISSUE | |
| ATE94759T1 (de) | Verwendung von dextransulfat, gegebenenfalls in kombination mit anti-androgenen mitteln zur behandlung des humanen protatakarzinoms. |